{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T14:41:45Z","timestamp":1782139305409,"version":"3.54.5"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.ejphar.2018.07.015","type":"journal-article","created":{"date-parts":[[2018,7,21]],"date-time":"2018-07-21T16:18:28Z","timestamp":1532189908000},"page":"118-125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Persistent therapeutic effect of a novel \u03b15-GABAA receptor antagonist in rodent preclinical models of vascular cognitive impairment"],"prefix":"10.1016","volume":"834","author":[{"given":"Istv\u00e1n","family":"Gacs\u00e1lyi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krisztina","family":"M\u00f3ricz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e1bor","family":"Gigler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin","family":"Megyeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferenc A.","family":"Antoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2018.07.015_bib1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.bbr.2005.09.005","article-title":"The role of the hippocampus in object recognition in rats: examination of the influence of task parameters and lesion size","volume":"167","author":"Ainge","year":"2006","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2018.07.015_bib2","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1001\/archpsyc.1997.01830220033006","article-title":"'Vascular depression' hypothesis","volume":"54","author":"Alexopoulos","year":"1997","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ejphar.2018.07.015_bib3","doi-asserted-by":"crossref","first-page":"37823","DOI":"10.1038\/srep37823","article-title":"Reducing GABAA-mediated inhibition improves forelimb motor function after focal cortical stroke in mice","volume":"6","author":"Alia","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2018.07.015_bib4","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.2174\/156802611795371314","article-title":"GABAA receptor subtype-selective modulators. II. alpha5-selective inverse agonists for cognition enhancement","volume":"11","author":"Atack","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejphar.2018.07.015_bib5","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1161\/STROKEAHA.110.592881","article-title":"Modulation of the post-ischemic immune response to improve stroke outcome","volume":"41","author":"Becker","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.ejphar.2018.07.015_bib6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.brainres.2006.07.123","article-title":"Use of TTC staining for the evaluation of tissue injury in the early phases of reperfusion after focal cerebral ischemia in rats","volume":"1116","author":"Benedek","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2018.07.015_bib7","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1177\/1545968314543652","article-title":"GABA levels are decreased after stroke and GABA changes during rehabilitation correlate with motor improvement","volume":"29","author":"Blicher","year":"2015","journal-title":"Neurorehabil. Neural Repair"},{"key":"10.1016\/j.ejphar.2018.07.015_bib8","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1152\/jn.00482.2007","article-title":"Alpha5GABAA receptors regulate the intrinsic excitability of mouse hippocampal pyramidal neurons","volume":"98","author":"Bonin","year":"2007","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.ejphar.2018.07.015_bib9","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1038\/nn.4102","article-title":"Regulating anxiety with extrasynaptic inhibition","volume":"18","author":"Botta","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejphar.2018.07.015_bib10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.neuron.2011.12.012","article-title":"Extrasynaptic GABA(A) receptors: their function in the CNS and implications for disease","volume":"73","author":"Brickley","year":"2012","journal-title":"Neuron"},{"issue":"3662\u20133667","key":"10.1016\/j.ejphar.2018.07.015_bib11","article-title":"Tonic inhibition in mouse hippocampal CA1 pyramidal neurons is mediated by alpha5 subunit-containing gamma-aminobutyric acid type A receptors","volume":"101","author":"Caraiscos","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2018.07.015_bib12","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1523\/JNEUROSCI.3771-09.2010","article-title":"Homeostatic regulation of synaptic excitability: tonic GABA(A) receptor currents replace I(h) in cortical pyramidal neurons of HCN1 knock-out mice","volume":"30","author":"Chen","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2018.07.015_bib13","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s10571-015-0208-4","article-title":"Chronic cerebral ischemia induces downregulation of A1 adenosine receptors during white matter damage in adult mice","volume":"35","author":"Cheng","year":"2015","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2018.07.015_bib14","doi-asserted-by":"crossref","first-page":"R725","DOI":"10.1016\/j.cub.2013.07.037","article-title":"Recognition memory: an old idea given new life","volume":"23","author":"Clark","year":"2013","journal-title":"Curr. Biol."},{"key":"10.1016\/j.ejphar.2018.07.015_bib15","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nature09511","article-title":"Reducing excessive GABA-mediated tonic inhibition promotes functional recovery after stroke","volume":"468","author":"Clarkson","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2018.07.015_bib16","doi-asserted-by":"crossref","first-page":"12312","DOI":"10.1523\/JNEUROSCI.1689-16.2016","article-title":"Effects of the selective alpha5-GABAAR Antagonist S44819 on excitability in the human brain: Aa TMS-EMG and TMS-EEG Phasephase I study","volume":"36","author":"Darmani","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2018.07.015_bib17","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1124\/jpet.105.092320","article-title":"An inverse agonist selective for alpha5 subunit-containing GABAA receptors enhances cognition","volume":"316","author":"Dawson","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2018.07.015_bib18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nprot.2006.2","article-title":"T-maze alternation in the rodent","volume":"1","author":"Deacon","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejphar.2018.07.015_bib19","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1159\/000332205","article-title":"Interleukin-1 and stroke: biomarker, harbinger of damage, and therapeutic target","volume":"32","author":"Denes","year":"2011","journal-title":"Cerebrovasc. Dis."},{"key":"10.1016\/j.ejphar.2018.07.015_bib20","doi-asserted-by":"crossref","unstructured":"Duncombe, J., Kitamura, A., Hase, Y., Ihara, M., Kalaria, R.N., Horsburgh, K., 2017. Chronic cerebral hypoperfusion: a key mechanism leading to vascular cognitive impairment and dementia. Closing the translational gap between rodent models and human vascular cognitive impairment and dementia. Clin. Sci. (Lond.) 131, pp. 2451\u20132468.","DOI":"10.1042\/CS20160727"},{"key":"10.1016\/j.ejphar.2018.07.015_bib21","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.neuropharm.2017.08.012","article-title":"Selective targeting of extra-synaptic \u03b15-GABAA receptors by a new therapeutic agent S44819 (Egis-13529)","volume":"125","author":"Etherington","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2018.07.015_bib22","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.neuropharm.2017.07.005","article-title":"Behavioural pharmacology of the alpha5-GABAA receptor antagonist S44819: enhancement and remediation of cognitive performance in preclinical models","volume":"125","author":"Gacs\u00e1lyi","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2018.07.015_bib23","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0166-4328(01)00296-0","article-title":"Behavioral tests of hippocampal function: simple paradigms complex problems","volume":"125","author":"Gerlai","year":"2001","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2018.07.015_bib24","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1161\/STR.0b013e3182299496","article-title":"Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association\/AmericanStroke Association","volume":"42","author":"Gorelick","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.ejphar.2018.07.015_bib25","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejphar.2005.06.031","article-title":"The effects of AMPA receptor antagonists in models of stroke and neurodegeneration","volume":"519","author":"Gressens","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.07.015_bib26","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12916-017-0793-9","article-title":"Translational models for vascular cognitive impairment: a review including larger species","volume":"15","author":"Hainsworth","year":"2017","journal-title":"BMC Med."},{"key":"10.1016\/j.ejphar.2018.07.015_bib27","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1093\/brain\/awv360","article-title":"Enhanced phasic GABA inhibition during the repair phase of stroke: a novel therapeutic target","volume":"139","author":"Hiu","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.ejphar.2018.07.015_bib28","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.neuron.2013.10.008","article-title":"The pathobiology of vascular dementia","volume":"80","author":"Iadecola","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2018.07.015_bib29","first-page":"6","article-title":"Reduced tonic inhibition after stroke promotes motor performance and epileptic seizures","author":"Jaenisch","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2018.07.015_bib30","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00401-016-1571-z","article-title":"Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer's disease","volume":"131","author":"Kalaria","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ejphar.2018.07.015_bib31","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1177\/1545968313520411","article-title":"Functional recovery after ischemic stroke is associated with reduced GABAergic inhibition in the cerebral cortex: a GABA PET study","volume":"28","author":"Kim","year":"2014","journal-title":"Neurorehabil. Neural Repair"},{"key":"10.1016\/j.ejphar.2018.07.015_bib32","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1161\/01.STR.0000181075.77897.0e","article-title":"Chronic mild reduction of cerebral perfusion pressure induces ischemic tolerance in focal cerebral ischemia","volume":"36","author":"Kitagawa","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.ejphar.2018.07.015_bib33","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1038\/jcbfm.2015.86","article-title":"The effects of delayed reduction of tonic inhibition on ischemic lesion and sensorimotor function","volume":"35","author":"Lake","year":"2015","journal-title":"J. Cereb. Blood Flow\u00a0Metab."},{"key":"10.1016\/j.ejphar.2018.07.015_bib34","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.nbd.2013.06.014","article-title":"Transient focal cerebral ischemia induces long-term cognitive function deficit in an experimental ischemic stroke model","volume":"59","author":"Li","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejphar.2018.07.015_bib35","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.ejphar.2015.07.005","article-title":"A novel GABA(A) alpha 5 receptor inhibitor with therapeutic potential","volume":"764","author":"Ling","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.07.015_bib36","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/01.STR.20.1.84","article-title":"Reversible middle cerebral artery occlusion without craniectomy in rats","volume":"20","author":"Longa","year":"1989","journal-title":"Stroke"},{"key":"10.1016\/j.ejphar.2018.07.015_bib37","first-page":"5","article-title":"Early treatment of minocycline alleviates white matter and cognitive impairments after chronic cerebral hypoperfusion","author":"Ma","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2018.07.015_bib38","unstructured":"Marta, P., Facchin, L., Adamantidis, A., Machado, P., Hermann, D.M., Bassetti, C.L., 2016. Gamma aminobutyric acid receptor antagonist promotes functional neurological recovery after permanent distal middle cerebral artery occlusion in rats. Abstracts of the 18th Annual Meeting of the Swiss Society for Neuroscience, Lausanne, p.31 abstract G18."},{"key":"10.1016\/j.ejphar.2018.07.015_bib39","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1523\/JNEUROSCI.4209-09.2010","article-title":"Alpha5GABAA receptor activity sets the threshold for long-term potentiation and constrains hippocampus-dependent memory","volume":"30","author":"Martin","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2018.07.015_bib40","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12916-017-0779-7","article-title":"Post-stroke dementia - a comprehensive review","volume":"15","author":"Mijajlovic","year":"2017","journal-title":"BMC Med."},{"key":"10.1016\/j.ejphar.2018.07.015_bib41","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bbr.2012.12.016","article-title":"PWZ-029, an inverse agonist selective for alpha(5) GABAAreceptors, improves object recognition, but not water-maze memory in normal and scopolamine-treated rats","volume":"241","author":"Milic","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2018.07.015_bib42","unstructured":"M\u00f6hler, H., Rudolph, U., 2017. Disinhibition, an emerging pharmacology of learning and memory F1000Research 6, (doi: 10.12688\/f11000research.19947.12681)."},{"key":"10.1016\/j.ejphar.2018.07.015_bib43","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.neuropharm.2017.10.042","article-title":"Loop F of the GABAA receptor alpha subunit governs GABA potency","volume":"128","author":"P\u00e1lv\u00f6lgyi","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2018.07.015_bib44","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.neurobiolaging.2012.06.025","article-title":"Effects of mild chronic cerebral hypoperfusion and early amyloid pathology on spatial learning and the cellular innate immune response in mice","volume":"34","author":"Pimentel-Coelho","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ejphar.2018.07.015_bib45","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.expneurol.2008.08.014","article-title":"VEGF overexpression improves mice cognitive abilities after unilateral common carotid artery occlusion","volume":"214","author":"Plaschke","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2018.07.015_bib46","first-page":"6","article-title":"Chronic cerebral hypoperfusion enhances Tau hyperphosphorylation and reduces autophagy in Alzheimer's disease mice","author":"Qiu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2018.07.015_bib47","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/S0028-3908(96)00061-5","article-title":"[3H]L-655,708, a novel ligand selective for the benzodiazepine site of GABAA receptors which contain the alpha 5 subunit","volume":"35","author":"Quirk","year":"1996","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2018.07.015_bib48","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00213-011-2593-9","article-title":"Negative modulation of GABAA alpha5 receptors by RO4938581 attenuates discrete sub-chronic and early postnatal phencyclidine (PCP)-induced cognitive deficits in rats","volume":"221","author":"Redrobe","year":"2012","journal-title":"Psychopharmacol. (Berl.)"},{"key":"10.1016\/j.ejphar.2018.07.015_bib49","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1146\/annurev-pharmtox-011613-135947","article-title":"GABAA receptor subtypes: therapeutic potential in Down syndrome, affective disorders, schizophrenia, and autism","volume":"54","author":"Rudolph","year":"2014","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2018.07.015_bib50","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/B978-0-444-52901-5.00001-0","article-title":"Neural plasticity and its contribution to functional recovery","volume":"110","author":"Sharma","year":"2013","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.ejphar.2018.07.015_bib51","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1177\/0271678X16638349","article-title":"In vivo evidence for long-term vascular remodeling resulting from chronic cerebral hypoperfusion in mice","volume":"37","author":"Struys","year":"2017","journal-title":"J. Cereb. Blood Flow\u00a0Metab."},{"key":"10.1016\/j.ejphar.2018.07.015_bib52","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1177\/0271678X16654921","article-title":"Systematic and detailed analysis of behavioural tests in the rat middle cerebral artery occlusion model of stroke: tests for long-term assessment","volume":"37","author":"Trueman","year":"2017","journal-title":"J. Cereb. Blood Flow.\u00a0Metab."},{"key":"10.1016\/j.ejphar.2018.07.015_bib53","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.celrep.2012.08.022","article-title":"Memory deficits induced by inflammation are regulated by alpha5-subunit-containing GABAA receptors","volume":"2","author":"Wang","year":"2012","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejphar.2018.07.015_bib54","unstructured":"Wang, Y.-.C., Sanchez-Mendoza, E., Silva de Carvalho, T., Kaltwasser, B., Doeppner, T.R., Hermann, D.M., Machado, P., Bassetti, C.L., 2017. Post-acute delivery of GABAA \u03b15 antagonist S44819 promotes neurological recovery and peri-infarct brain remodeling after transient focal cerebral ischemia in mice. Abstracts of the 3rd Congress of the European Academy of Neurology, EP3031."},{"key":"10.1016\/j.ejphar.2018.07.015_bib55","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.expneurol.2007.12.005","article-title":"Chronic cerebral hypoperfusion induced by right unilateral common carotid artery occlusion causes delayed white matter lesions and cognitive impairment in adult mice","volume":"210","author":"Yoshizaki","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2018.07.015_bib56","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0285-16.2017","article-title":"A negative allosteric modulator for alpha5 subunit-containing gaba receptors exerts a rapid and persistent antidepressant-like action without the side effects of the NMDA receptor antagonist ketamine in mice","volume":"4","author":"Zanos","year":"2017","journal-title":"eNeuro"},{"key":"10.1016\/j.ejphar.2018.07.015_bib57","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s12975-015-0412-z","article-title":"Neurobehavioral and imaging correlates of hippocampal atrophy in a mouse model of vascular cognitive impairment","volume":"6","author":"Zuloaga","year":"2015","journal-title":"Transl. Stroke Res."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918303832?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918303832?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T22:47:43Z","timestamp":1561070863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299918303832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":57,"alternative-id":["S0014299918303832"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.07.015","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Persistent therapeutic effect of a novel \u03b15-GABAA receptor antagonist in rodent preclinical models of vascular cognitive impairment","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}